0

University of Washington Seeking Patients for Neurological Study

University of Washington Seeking Patients for Neurological Study

By National Institute of Neurological Disorders and Stroke

Approximately 50,000 infants per year (961 per week) are born at less than 28 weeks of gestation in the US. Cerebral palsy, deafness, blindness, and/or mental retardation are present in up to 50% of surviving extremely preterm infants at school age. Perinatal care costs for these infants exceed US$18 billion every year. The burden of extreme prematurity to each patient and to society is further magnified by the years of productive life lost. New therapies are needed to improve these outcomes.

Recombinant human erythropoietin (Epo) is a promising novel neuroprotective agent. Epo decreases neuronal programmed cell death resulting from brain injury; it has anti-inflammatory effects, increases neurogenesis, and protects oligodendrocytes from injury.

We hypothesize that neonatal Epo treatment of ELGANs will decrease the combined outcome of death or severe NDI from 40% to 30% (primary outcome), or the combined outcome of death plus moderate or severe NDI from 60% to 40% (secondary outcome) measured at 24-26 months corrected age.

Read the full story.

Rate this post

FREE MEDICAL AND LEGAL RESOURCES

The Cerebral Palsy Survival Guide is a free, state-specific resource list for everything from everyday activities to emergency situations.

BI-WEEKLY E-NEWSLETTER SIGN-UP

Sign up for our e-newsletter to receive the latest in CP news, resources and

LATEST BLOG POSTS

Happy 10th Anniversary, CPFN!

By Lee Vander Loop What an exciting milestone! As an editor of the Cerebral Palsy Family Network, I’m honored to write this blog to commemorate this anniversary and reflect on…

Read more

10 Years After Lizzy’s Trial: Taking Care of Lizzy For Life. Thanks, Ken Suggs (p.3)

(Looking Back and Moving Forward – continued) The doctor’s attorney asked questions about “studies” and past testing from others and how this case compares. They were hoping for some genetic…

Read more